Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota and host innate immune system constitute a complex, bidirectional communication axis essential for maintaining physiological homeostasis and immune tolerance (Belkaid & Hand, 2014, Science). The innate immune system utilizes pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), to sense microbe-associated molecular patterns (MAMPs) and metabolites like short-chain fatty acids (SCFAs) produced by commensal bacteria (Hooper et al., 2012, Science). This interaction is critical for the maturation of immune cells, the maintenance of the intestinal epithelial barrier, and the prevention of pathogen colonization (Thaiss et al., 2016, Nature). Dysregulation of this axis, often termed dysbiosis, is linked to a wide range of pathologies, including inflammatory bowel disease (IBD), obesity, and autoimmune disorders (Zheng et al., 2020, Cell Research). Therapeutic strategies targeting this system include the use of probiotics, prebiotics, and fecal microbiota transplants to restore a healthy microbial balance and modulate host immune signaling (Cani, 2018, Gut). Because this entry describes a broad physiological interaction involving numerous distinct proteins and organisms rather than a single molecular entity, it is classified as a biological system or axis.
Modulation of the intestinal microbial ecosystem and its metabolic byproducts to regulate host innate immune signaling via pattern recognition receptors (PRRs) and maintain epithelial barrier integrity (Belkaid & Hand, 2014, Science; Cani, 2018, Gut).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota-host innate immune system axis.